📊 Evidence-Based Reference

vasco tip vascoflange

Vascor Medical

Summary: The vasco tip vascoflange by Vascor Medical is an IVC filter device, primarily used to prevent pulmonary embolism. Key evidence findings are not available from the provided studies.

FDA Clearance Information

Pathway 510K
Decision Date August 25, 1993
Product Code DTB
Device Class Class 3
Evidence 0 studies

The vasco tip vascoflange received FDA clearance through the 510(k) pathway on August 25, 1993. It is manufactured by Vascor Medical and classified as a Class III device.

What It Is

The vasco tip vascoflange is an inferior vena cava (IVC) filter designed to prevent blood clots from traveling to the lungs, thereby reducing the risk of pulmonary embolism. It is intended for use in patients at risk of thromboembolic events.

Clinical Applications

This device is commonly used in clinical scenarios where patients are at high risk for pulmonary embolism and anticoagulation therapy is contraindicated or ineffective. It is typically deployed in the inferior vena cava to capture emboli.

Evidence Summary

The available literature includes 10 studies, though none directly pertain to the vasco tip vascoflange. The studies span various years and cover different topics unrelated to this device.

Reported Outcomes

Published studies report no specific efficacy findings for the vasco tip vascoflange, as the provided evidence does not include relevant clinical trials or outcomes related to this device.

Safety Profile

Reported complications include no specific safety data for the vasco tip vascoflange, as the provided evidence does not address adverse events or complications associated with this device.

Evidence Limitations

The evidence lacks direct studies on the vasco tip vascoflange, highlighting a significant gap in clinical data. Further research is needed to evaluate its efficacy and safety in real-world settings.

Frequently Asked Questions

What are the clinical indications for vasco tip vascoflange?

The vasco tip vascoflange is indicated for preventing pulmonary embolism in patients where anticoagulation is not suitable.

What outcomes have been reported in clinical studies?

No specific outcomes have been reported in the provided evidence for the vasco tip vascoflange.

What complications have been reported?

No specific complications have been reported in the provided evidence for the vasco tip vascoflange.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.